150 results
Goal-Directed Therapy - Evidence Summary of Major Clinical Trials

 - EGDT: NEJM 2001

 - ProCESS: NEJM
Summary of Major Clinical ... Trials - EGDT: NEJM ... - ProCESS: NEJM ... - ProMlSe: NEJM ... Therapy #Trials #EBM
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table #NEJM
Bilateral Patellar Clonus on Physical Exam
 
Clonus Associated w/Tropical Spastic Paraparesis. 

#Knee #Patellar #Clonus #PhysicalExam #Clinical
Patellar #Clonus #PhysicalExam ... #Clinical #Video ... #Neurology #NEJM
Major Clinical Trials and Evidence Summary for Transfusion Thresholds in Critical Care

TRICC - NEJM 1999 -
Major Clinical Trials ... Thresholds in Critical ... Care TRICC - NEJM ... - ICU FOCUS - NEJM ... /vmoitra) #EBM
A 48-year-old-man presented to the dermatology clinic with a whitish discoloration and hyperkeratosis of the first
the dermatology clinic ... first toenail that had ... microconidia that had ... #Clinical #IM #InfectiousDisease ... RapidProgression #NEJM
Regression of Clubbing after Treatment of Lung Cancer #Clinical #PhysicalExam #Radiology #Clubbing #Regression #LungCancer #CT #NEJM
of Lung Cancer #Clinical ... #PhysicalExam # ... LungCancer #CT #NEJM
The HYPERION Trial - Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm - Visual Abstract

NEJM
Visual Abstract NEJM ... with coma who had ... C for 24 hours led ... VisualAbstract #EBM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Double Apical Impulse (S4) Visualization on Physical Exam - A small stick taped to the chest
a patient who had ... Impulse #S4 #Gallop #PhysicalExam ... #Video #Signs # ... Cardiology #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM